SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
PFE (Pfizer) How high will it go?
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
9523 158 0 PFE
Emcee:  Lynn Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
8998Pfizer reported adjusted diluted EPS of .51 per share for the quarter ending DecQualified Opinion-1/20/2006
8997Generics Eat Into Pfizer's Profit; Costs Offset Novartis Sales Gain <i&gDoc Bones-1/20/2006
8996Same thing, more words and a more positive headline. Numbers beat the expectatiRichard Saunders-1/19/2006
8995Pfizer 4Q Profit Slips As Revenue Falls Thursday January 19, 8:16 am ET PfizDoc Bones-1/19/2006
8994Pfizer to Acquire the Sanofi-Aventis Worldwide Rights to Exubera(R) (Inhaled HumQualified Opinion-1/12/2006
8993On HDL, remember Pfizer bought Esperion in 2003,excerpt: NEW YORK (Reuters) - PQualified Opinion-1/6/2006
8992Excerpt: Pfizer researchers also presented data from a separate study involving Qualified Opinion-1/6/2006
8990FDA on HDL and LDL, excerpt: Two types of lipoproteins and their quantity in thQualified Opinion-1/6/2006
8989Rob: There’s an iHub thread this evening about Torcetrapib that you might find DewDiligence_on_SI-1/6/2006
8988I caught it. Next target date is Jan. 27th for Exubera.Qualified Opinion-1/6/2006
8987<i>WSJ failed to explain the surge in sales of the cholesterol lowering drDewDiligence_on_SI-1/6/2006
8986Correction - WSJ failed to explain the surge in sales of the cholesterol lowerinQualified Opinion-1/5/2006
8985WSJ failed to explain the surge in sales of the cholesterol lowering drugs in thQualified Opinion-1/5/2006
8984Pfizer has four potential blockbuster drugs candidates up for FDA approval durinQualified Opinion-1/5/2006
8983As Generics Pummel Its Drugs, Pfizer Faces Uncertain Future Side Effects InsureDoc Bones-1/5/2006
8982Chicago — Two new studies deal a double blow to hopes that cholesterol-lowering Stephen O-1/3/2006
8981(Thank you Nigel) INCYTE CORP Conference Call to Discuss Collaborative Research Qualified Opinion-1/3/2006
8980MAay, 2005 New Data Show Pfizer's SUTENT/SU11248 Extends Overall Survival inQualified Opinion-12/31/2005
8979The label states the side effects. It's up to the doctor to perform properlyQualified Opinion-12/31/2005
8978Lipitor wrongful death lawsuit > > November 30, 2005 > > "PStephen O-12/31/2005
8977Pfizer Invites Public to Listen to Webcast of January 4 Conference ParticipationQualified Opinion-12/31/2005
8976Early in the year, Pfizer forecasted double digit earnings growth in 2006 and 20Qualified Opinion-12/31/2005
8975The market looking ahead and seeing all is not well with their biggest selling dStephen O-12/31/2005
8974Since the press release on May 16, 2005 PFE has gone down 15%. Any reason for thNoel de Leon-12/31/2005
89732005 - Pfizer Takes Cancer By Storm Matthew Herper, 05.16.05, 12:00 PM ET By Qualified Opinion-12/31/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News